• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用格列本脲和miR-223抑制NLRP3对结直肠癌的影响。

Implications of NLRP3 Suppression Using Glibenclamide and miR-223 against Colorectal Cancer.

作者信息

Hamza Shaimaa, Garanina Ekaterina E, Shkair Layaly, Alsaadi Mohammad, Khaiboullina Svetlana F, Tezcan Gulcin

机构信息

Institute of Fundamental Medicine and Biology, Kazan Federal University, 420008 Kazan, Russia.

Department of Fundamental Sciences, Faculty of Dentistry, Bursa Uludag University, Bursa 16059, Turkey.

出版信息

Pharmaceuticals (Basel). 2024 Feb 26;17(3):299. doi: 10.3390/ph17030299.

DOI:10.3390/ph17030299
PMID:38543085
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10975274/
Abstract

The NLR family pyrin domain containing 3 (NLRP3) promotes the growth of colorectal cancer (CRC). However, the therapeutic effect of NLRP3 inhibition on CRC cell progression is controversial. This study comparatively investigated the therapeutic effect of a pharmacological NLRP3 inhibitor, glibenclamide (gli), and the post-translational suppression of NLRP3 by miR-223 on CRC cell progression in HCT-116 and HCT-15 cells. LPS and ATP were used to activate Gli-treated and LSB-hsa-miR-223-3p (WT)-expressing HCT-116 cells. NLRP3.AB.pCCL.sin.cPPT.U6.miR-223-Decoy.hPGK.GFP.WPRE plasmid (D) was the negative control for miR-223 expression. NLRP3, gasdermin D, and BAX expressions were analyzed using western blotting. Real-time PCR detected the RNA expression of autophagy-related genes ATG5, BECN1, and miR-223 in non-transfected cells. ELISA analyzed IL-1β and IL-18 in the medium. MTS-1, annexin V, wound-healing, and sphere-invasion assays were used to assess cell viability and progression. A multiplex cytokine assay detected proinflammatory cytokine secretion. LPS-ATP-activated NLRP3 produced gasdermin D cleavage, released IL-1b and IL-18, and activated cell migration and sphere invasion. In contrast, reduced cell growth, miR-223 expression, IFN-γ, CXCL10, and LIF secretion were found in cells after inflammasome activation. Both gli and WT induced autophagy genes ATG5 and BECN1 and reduced the NLRP3 activation and its downstream proteins. However, while gli had a limited effect on the production of IFN-γ, CXCL10, and LIF, WTmiR-223 increased the release of those cytokines. In addition, gli did not suppress cell growth, while WTmiR-223 promoted apoptosis. Notably, neither gli nor WTmiR-223 effectively prevented sphere invasion. These data suggest that, while WT could have a better anticancer effect in CRC compared to gli, the sole usage of miR-223-mediated NLRP3 suppression may not be sufficient to prevent CRC metastasis.

摘要

含NLR家族pyrin结构域蛋白3(NLRP3)促进结直肠癌(CRC)的生长。然而,抑制NLRP3对CRC细胞进展的治疗效果存在争议。本研究比较了药理学NLRP3抑制剂格列本脲(gli)和miR - 223对NLRP3的翻译后抑制作用对HCT - 116和HCT - 15细胞中CRC细胞进展的治疗效果。使用脂多糖(LPS)和三磷酸腺苷(ATP)激活经Gli处理和表达LSB - hsa - miR - 223 - 3p(野生型,WT)的HCT - 116细胞。NLRP3.AB.pCCL.sin.cPPT.U6.miR - 223 - Decoy.hPGK.GFP.WPRE质粒(D)是miR - 223表达的阴性对照。使用蛋白质免疫印迹法分析NLRP3、gasdermin D和BAX的表达。实时定量聚合酶链反应(Real - time PCR)检测未转染细胞中自噬相关基因ATG5、BECN1和miR - 223的RNA表达。酶联免疫吸附测定(ELISA)分析培养基中的白细胞介素 - 1β(IL - 1β)和白细胞介素 - 18(IL - 18)。使用MTS - 1、膜联蛋白V、伤口愈合和球体侵袭试验评估细胞活力和进展。多重细胞因子检测法检测促炎细胞因子的分泌。LPS - ATP激活的NLRP3产生gasdermin D裂解,释放IL - 1β和IL - 18,并激活细胞迁移和球体侵袭。相反,在炎性小体激活后的细胞中发现细胞生长、miR - 223表达、干扰素 - γ(IFN - γ)、CXC趋化因子配体10(CXCL10)和白血病抑制因子(LIF)分泌减少。gli和WT均诱导自噬基因ATG5和BECN1,并降低NLRP3激活及其下游蛋白。然而,虽然gli对IFN - γ、CXCL10和LIF的产生影响有限,但WT miR - 223增加了这些细胞因子的释放。此外,gli不抑制细胞生长,而WT miR - 223促进细胞凋亡。值得注意的是,gli和WT miR - 223均不能有效阻止球体侵袭。这些数据表明,虽然与gli相比,WT在CRC中可能具有更好的抗癌效果,但单独使用miR - 223介导的NLRP3抑制可能不足以预防CRC转移。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af4d/10975274/9944dc951918/pharmaceuticals-17-00299-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af4d/10975274/f0484f381afe/pharmaceuticals-17-00299-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af4d/10975274/619430886ad7/pharmaceuticals-17-00299-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af4d/10975274/1cb689ffc7a0/pharmaceuticals-17-00299-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af4d/10975274/20e85c10601e/pharmaceuticals-17-00299-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af4d/10975274/c07fe3231d15/pharmaceuticals-17-00299-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af4d/10975274/9944dc951918/pharmaceuticals-17-00299-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af4d/10975274/f0484f381afe/pharmaceuticals-17-00299-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af4d/10975274/619430886ad7/pharmaceuticals-17-00299-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af4d/10975274/1cb689ffc7a0/pharmaceuticals-17-00299-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af4d/10975274/20e85c10601e/pharmaceuticals-17-00299-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af4d/10975274/c07fe3231d15/pharmaceuticals-17-00299-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af4d/10975274/9944dc951918/pharmaceuticals-17-00299-g006.jpg

相似文献

1
Implications of NLRP3 Suppression Using Glibenclamide and miR-223 against Colorectal Cancer.使用格列本脲和miR-223抑制NLRP3对结直肠癌的影响。
Pharmaceuticals (Basel). 2024 Feb 26;17(3):299. doi: 10.3390/ph17030299.
2
MicroRNA-22 suppresses NLRP3/CASP1 inflammasome pathway-mediated proinflammatory cytokine production by targeting the HIF-1α and NLRP3 in human dental pulp fibroblasts.microRNA-22 通过靶向人牙髓成纤维细胞中的 HIF-1α 和 NLRP3 抑制 NLRP3/CASP1 炎性小体通路介导的促炎细胞因子产生。
Int Endod J. 2022 Nov;55(11):1225-1240. doi: 10.1111/iej.13814. Epub 2022 Aug 25.
3
Therapeutic Potential of Pharmacological Targeting NLRP3 Inflammasome Complex in Cancer.药理学靶向NLRP3炎性小体复合物在癌症中的治疗潜力
Front Immunol. 2021 Feb 3;11:607881. doi: 10.3389/fimmu.2020.607881. eCollection 2020.
4
Effect of miR-223-3p on cell pyroptosis in myelodysplastic syndrome and its mechanism via regulating the expression of NLRP3.miR-223-3p 通过调控 NLRP3 表达对骨髓增生异常综合征细胞焦亡的影响及其机制
Cell Mol Biol (Noisy-le-grand). 2022 Feb 28;68(2):31-41. doi: 10.14715/cmb/2022.68.2.5.
5
MicroRNA-223 negatively regulates LPS-induced inflammatory responses by targeting NLRP3 in human dental pulp fibroblasts.microRNA-223 通过靶向人牙髓成纤维细胞中的 NLRP3 负调控 LPS 诱导的炎症反应。
Int Endod J. 2021 Feb;54(2):241-254. doi: 10.1111/iej.13413. Epub 2020 Oct 17.
6
NLRP3 Inflammasome Activation in MΦs-CRC Crosstalk Promotes Colorectal Cancer Metastasis.NLRP3 炎性小体在 MΦs-CRC 串扰中激活促进结直肠癌转移。
Ann Clin Lab Sci. 2022 Jul;52(4):571-579.
7
miR-99b-3p/Mmp13 axis regulates NLRP3 inflammasome-dependent microglial pyroptosis and alleviates neuropathic pain via the promotion of autophagy.miR-99b-3p/Mmp13 轴通过促进自噬来调节 NLRP3 炎性体依赖性小胶质细胞焦亡,从而减轻神经病理性疼痛。
Int Immunopharmacol. 2024 Jan 5;126:111331. doi: 10.1016/j.intimp.2023.111331. Epub 2023 Dec 6.
8
Protective Effects of Microrna-22 Against Endothelial Cell Injury by Targeting NLRP3 Through Suppression of the Inflammasome Signaling Pathway in a Rat Model of Coronary Heart Disease.微小RNA-22通过靶向NLRP3抑制冠心病大鼠模型中的炎性小体信号通路对内皮细胞损伤的保护作用
Cell Physiol Biochem. 2017;43(4):1346-1358. doi: 10.1159/000481846. Epub 2017 Oct 9.
9
Aloe vera downregulates LPS-induced inflammatory cytokine production and expression of NLRP3 inflammasome in human macrophages.芦荟下调脂多糖诱导的人巨噬细胞中炎症细胞因子的产生和 NLRP3 炎性体的表达。
Mol Immunol. 2013 Dec;56(4):471-9. doi: 10.1016/j.molimm.2013.05.005. Epub 2013 Aug 1.
10
MicroRNA-223-3p inhibits oxidized low-density lipoprotein-mediated NLRP3 inflammasome activation via directly targeting NLRP3 and FOXO3.miR-223-3p 通过直接靶向 NLRP3 和 FOXO3 抑制氧化型低密度脂蛋白介导的 NLRP3 炎性小体激活。
Clin Hemorheol Microcirc. 2022;81(3):241-253. doi: 10.3233/CH-211232.

引用本文的文献

1
Maternal prenatal stress induces sex-dependent changes in tRNA fragment families and cholinergic pathways in newborns.母亲产前压力会导致新生儿tRNA片段家族和胆碱能通路出现性别依赖性变化。
Mol Psychiatry. 2025 Apr 5. doi: 10.1038/s41380-025-03011-2.
2
Anti-Diabetic Therapies and Cancer: From Bench to Bedside.抗糖尿病治疗与癌症:从基础到临床。
Biomolecules. 2024 Nov 20;14(11):1479. doi: 10.3390/biom14111479.
3
Inflammasomes Are Influenced by Epigenetic and Autophagy Mechanisms in Colorectal Cancer Signaling.炎性小体受结直肠癌信号转导中表观遗传和自噬机制的影响。

本文引用的文献

1
Mechanisms and effects of NLRP3 in digestive cancers.NLRP3在消化系统癌症中的机制与作用
Cell Death Discov. 2024 Jan 5;10(1):10. doi: 10.1038/s41420-023-01783-6.
2
Glibenclamide-Loaded Engineered Nanovectors (GNVs) Modulate Autophagy and NLRP3-Inflammasome Activation.载有格列本脲的工程化纳米载体(GNV)调节自噬和NLRP3炎性小体激活。
Pharmaceuticals (Basel). 2023 Dec 13;16(12):1725. doi: 10.3390/ph16121725.
3
Simvastatin induces pyroptosis via ROS/caspase-1/GSDMD pathway in colon cancer.辛伐他汀通过 ROS/caspase-1/GSDMD 通路诱导结肠癌细胞发生细胞焦亡。
Int J Mol Sci. 2024 Jun 3;25(11):6167. doi: 10.3390/ijms25116167.
Cell Commun Signal. 2023 Nov 16;21(1):329. doi: 10.1186/s12964-023-01359-y.
4
Divergent functions of NLRP3 inflammasomes in cancer: a review.NLRP3 炎性体在癌症中的不同功能:综述。
Cell Commun Signal. 2023 Sep 15;21(1):232. doi: 10.1186/s12964-023-01235-9.
5
Inhibitors of the NLRP3 inflammasome pathway as promising therapeutic candidates for inflammatory diseases (Review).NLRP3 炎性小体通路抑制剂作为炎症性疾病有希望的治疗候选物(综述)。
Int J Mol Med. 2023 Apr;51(4). doi: 10.3892/ijmm.2023.5238. Epub 2023 Mar 24.
6
The Multifaceted Role and Regulation of Nlrp3 Inflammasome in Colitis-Associated Colo-Rectal Cancer: A Systematic Review.Nlrp3 炎性小体在结肠炎相关结直肠癌中的多效作用及其调控:系统评价。
Int J Mol Sci. 2023 Feb 9;24(4):3472. doi: 10.3390/ijms24043472.
7
Antioxidant and Chemopreventive Activity of Protein Hydrolysates from Raw and Germinated Flour of Legumes with Commercial Interest in Colorectal Cancer.具有商业价值的豆类生面粉和发芽面粉中蛋白质水解物的抗氧化及化学预防活性(针对结直肠癌)
Antioxidants (Basel). 2022 Dec 8;11(12):2421. doi: 10.3390/antiox11122421.
8
NLRP3 Inflammasome Activation in MΦs-CRC Crosstalk Promotes Colorectal Cancer Metastasis.NLRP3 炎性小体在 MΦs-CRC 串扰中激活促进结直肠癌转移。
Ann Clin Lab Sci. 2022 Jul;52(4):571-579.
9
Luteolin induces pyroptosis in HT-29 cells by activating the Caspase1/Gasdermin D signalling pathway.木犀草素通过激活半胱天冬酶1/ Gasdermin D信号通路诱导HT-29细胞发生焦亡。
Front Pharmacol. 2022 Aug 29;13:952587. doi: 10.3389/fphar.2022.952587. eCollection 2022.
10
MicroRNA-Based Diagnosis and Therapy.基于 microRNA 的诊断和治疗。
Int J Mol Sci. 2022 Jun 28;23(13):7167. doi: 10.3390/ijms23137167.